OFA
Oak Family Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
168,514
-14,228
| -8% | -$994K | 3.71% | 3 |
|
|
2025
Q1 | $13.4M | Sell |
182,742
-15,061
| -8% | -$1.11M | 4.52% | 1 |
|
|
2024
Q4 | $13M | Buy |
197,803
+58,833
| +42% | +$3.85M | 4.7% | 2 |
|
|
2024
Q3 | $10.8M | Sell |
138,970
-2,900
| -2% | -$226K | 3.33% | 3 |
|
|
2024
Q2 | $11.1M | Buy |
141,870
+2,744
| +2% | +$214K | 3.79% | 3 |
|
|
2024
Q1 | $9.43M | Buy |
139,126
+8,788
| +7% | +$595K | 3.62% | 3 |
|
|
2023
Q4 | $8.78M | Sell |
130,338
-4,429
| -3% | -$298K | 3.69% | 2 |
|
|
2023
Q3 | $9.13M | Buy |
134,767
+10,138
| +8% | +$687K | 4.31% | 1 |
|
|
2023
Q2 | $8.92M | Sell |
124,629
-14,582
| -10% | -$1.04M | 4.22% | 1 |
|
|
2023
Q1 | $9.66M | Sell |
139,211
-10,573
| -7% | -$734K | 4.76% | 1 |
|
|
2022
Q4 | $10.2M | Buy |
149,784
+9,271
| +7% | +$629K | 5.43% | 1 |
|
|
2022
Q3 | $7.71M | Buy |
140,513
+18,356
| +15% | +$1.01M | 4.12% | 2 |
|
|
2022
Q2 | $8.07M | Sell |
122,157
-5,367
| -4% | -$355K | 4.06% | 2 |
|
|
2022
Q1 | $8.46M | Buy |
127,524
+24,704
| +24% | +$1.64M | 3.31% | 3 |
|
|
2021
Q4 | $5.99M | Buy |
102,820
+9,779
| +11% | +$570K | 2.24% | 7 |
|
|
2021
Q3 | $5.59M | Buy |
93,041
+18,079
| +24% | +$1.09M | 2.04% | 6 |
|
|
2021
Q2 | $4.49M | Buy |
74,962
+9,718
| +15% | +$582K | 1.87% | 11 |
|
|
2021
Q1 | $3.24M | Buy |
65,244
+29,722
| +84% | +$1.48M | 1.41% | 14 |
|
|
2020
Q4 | $1.78M | Buy |
+35,522
| New | +$1.78M | 0.92% | 25 |
|